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Abstract
Background and Objective: Exposure to fine airborne particles (PM2.5) has been shown to be responsible for 
cardiovascular and hematological effects, especially in older people with cardiovascular disease. Some epidemiological 
studies suggest that individuals with diabetes may be a particularly susceptible population. This study examined 
effects of short-term exposures to ambient PM2.5 on markers of systemic inflammation, coagulation, autonomic control 
of heart rate, and repolarization in 22 adults (mean age: 61 years) with type 2 diabetes.
Methods: Each individual was studied for four consecutive days with daily assessments of plasma levels of blood 
markers. Cardiac rhythm and electrocardiographic parameters were examined at rest and with 24-hour ambulatory 
ECG monitors. PM2.5 and meteorological data were measured daily on the rooftop of the patient exam site. Data were 
analyzed with models adjusting for season, weekday, meteorology, and a random intercept. To identify susceptible 
subgroups, effect modification was analyzed by clinical characteristics associated with insulin resistance as well as with 
oxidative stress and by medication intake.
Results: Interleukin (IL)-6 and tumor necrosis factor alpha showed a significant increase with a lag of two days (percent 
change of mean level: 20.2% with 95%-confidence interval [6.4; 34.1] and 13.1% [1.9; 24.4], respectively) in association 
with an increase of 10 μg/m3 in PM2.5. Obese participants as well as individuals with elevated glycosylated hemoglobin, 
lower adiponectin, higher ferritin or with glutathione S-transferase M1 null genotype showed higher IL-6 effects. 
Changes in repolarization were found immediately as well as up to four days after exposure in individuals without 
treatment with a beta-adrenergic receptor blocker.
Conclusions: Exposure to elevated levels of PM2.5 alters ventricular repolarization and thus may increase myocardial 
vulnerability to arrhythmias. Exposure to PM2.5 also increases systemic inflammation. Characteristics associated with 
insulin resistance or with oxidative stress were shown to enhance the association.
Background
As a consequence of life-style patterns contributing to
obesity the number of people with diabetes in the United
States has reached 26.8 million in 2010 and by 2030 is
expected to affect 12% of adults (age: 20-79 years) as
compared to 10.3% today; worldwide 285 million people
have type 2 diabetes and by 2030, that number is
expected to rise to 439 million [1]. Metabolic abnormali-
ties caused by diabetes induce vascular dysfunction that
predisposes diabetic individuals to atherosclerosis and its
complications [2]. The risk of developing coronary, cere-
brovascular and peripheral vascular disease is increased
up to four-fold [2]. In addition, diabetic individuals have
greater disease progression and higher cardiovascular
mortality rates compared to non-diabetic individuals [3].
Individuals having diabetes have been shown to be at
greater risk for morbidity and mortality associated with
exposure to ambient air pollution particulate matter (PM)
[4,5]. Although many people with diabetes have second-
ary cardiovascular complications, as a group they show
larger responses to PM than people with cardiovascular
(CV) disease and no diabetes [6]. However, the mecha-
nisms accounting for the increased risk is unknown.
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Epidemiological as well as toxicological research have
shown PM-induced changes in autonomic nervous sys-
tem function [7-10] as well as in vascular factors involved
in inflammation and coagulation [11-16], particularly in
elderly people with CV disease. Since diabetic individuals
appear to have additional risk factors for PM-associated
mortality and morbidity beyond those found in people
with CV, we hypothesize that changes in these health
e n d p o i n t s  m i g h t  b e  e v e n  m o r e  p r o n o u n c e d  i n  p e o p l e
with diabetes than in people with CV disease without
diabetes, who have been characterized in other studies.
In this study we assessed the effects of ambient fine
particles (PM2.5) on repeated measures of cardiac auto-
nomic balance, systemic inflammation and coagulation in
individuals with type 2 diabetes. Fluctuations in daily air
pollution measurements from a local air monitoring sta-
tion were associated with changes in health effect param-
eters which provide information about responses by the
immune, vascular, cardiac, hematologic, and autonomic
nervous systems. To determine if severity of diabetes was
associated with increased responsiveness to PM, we ana-
lyzed effect modifications associated with insulin resis-
tance (obesity, age, poor glycemic control, adiponectin).
We also analyzed effect modifications associated with
markers of oxidative stress or potential markers of sus-
ceptibility to oxidative stress (myeloperoxidase (MPO),
ferritin and glutathione S-transferase M1 (GSTM1)), and
medication usage (beta-blockers, statins, and aspirin).
Materials and methods
Study population
Twenty-two volunteers, aged 48-78, with type 2 diabetes
were identified through the University of North Carolina
(UNC) Diabetes Clinic and through newspaper advertise-
ments. Details on the inclusion and exclusion criteria
have been previously published [17]. Potential partici-
pants had to have a diagnosis of type 2 diabetes, but with-
out taking insulin; and be on a stable medication regimen
throughout their participation. Volunteers were excluded
if they had a recent vascular event or intervention such as
coronary artery graft bypass surgery or percutaneous
coronary intervention. Participants were asked to refrain
from vigorous exercise on study-mornings and to refrain
from medications like anti-oxidants (vitamins C and E),
fish oil, niacin, arginine, over-the-counter vasoactive
agents such as decongestants, anti-inflammatory agents
such as ibuprofen, naproxen or aspirin unless it was pre-
scribed as a daily medication (in which case it was contin-
ued) for the week prior to the study as well as the week of
the study. Participants were also asked to refrain from use
of phosphodiesterase enzyme inhibitors during the week
of the study.
Each participant visited the U.S. Environmental Protec-
tion Agency's National Health Effects Environmental
Laboratory, Environmental Public Health Division
(EPHD) in Chapel Hill, NC, on five consecutive weekdays
between November 2004 and December 2005. Data on
health status, pulmonary and cardiac symptoms, medica-
tion, and smoking history were obtained at baseline and
during four follow-up visits. Altogether a maximum of 88
observations were available for analysis, depending on
the examined health outcome. All volunteers signed a
written consent form and the study protocol was
approved by the UNC Human Studies Biomedical Insti-
tutional Review Board as well as by the EPA.
Clinical measurements
Clinical procedures
On Monday morning of each examination week the par-
ticipants completed a baseline questionnaire. In each of
the next four mornings, participants checked into the
medical station in a fasting state and without having
taken their anti-diabetic medication. Upon arriving at the
medical station each morning, fasting glucose concentra-
tion was measured with a point of care glucose meter.
Venipuncture and assays
Each morning approximately 60 ml of peripheral venous
blood of was taken from an antecubital site. Both serum
and plasma were obtained and stored at -80°C. Differen-
tial cell counts, clinical chemistry endpoints, and inflam-
mation and coagulation markers were selected because
previous studies suggested they may change in associa-
tion with PM (Table 1).
Basic blood chemistry, blood lipids, ferritin, glycosy-
lated hemoglobin A1c (HbA1c), homocysteine, albumin
and complete blood counts with differential were mea-
sured and calculated by LabCorp (Burlington, NC) on the
day the blood was drawn. HbA1c was only measured
from the first blood sample. C-reactive protein (CRP) lev-
els were quantified using a commercially available
enzyme-linked immunosorbent assays (ELISA) kit pur-
chased from Alpco Diagnostics (Salem, NH). Paired anti-
b o d i e s  w e r e  p u r c h a s e d  f r o m  E n z y m e  R e s e a r c h  L a b s
(South Bend, IN) and used to develop ELISA assays to
quantify levels of fibrinogen, protein C, factor VII, factor
IX, plasminogen, and tissue plasminogen activator (t-PA).
Similarly, ELISA assays were developed using paired anti-
bodies for D-dimers and von Willebrand factor (vWf)
purchased from Diagnostica Stago (Asnieres-Sur-Seine,
France). Myeloperoxidase (MPO), soluble intercellular
adhesion molecule (s-ICAM)-1, soluble vascular cell
adhesion molecule (s-VCAM)-1, soluble endothelial-leu-
kocyte adhesion molecule (E-selectin), plasminogen acti-
vator inhibitor (PAI)-1, tumor necrosis factor alpha
(TNFα), and interleukin (IL)-6 were quantified using
commercially available ELISA kits purchased from Linco-
plex (Linco Research, Inc., St. Charles, MO) and run on a
Luminex 100 Multiplex system. Adiponectin levels wereSchneider et al. Particle and Fibre Toxicology 2010, 7:14
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measured using a commercially available kit purchased
from R&D Systems (Minneapolis, MN).
Regarding genetics, we measured the null-polymor-
phism of glutathione S-transferase M1 (GSTM1), a gene
that belongs to the antioxidant defense family. DNA was
isolated from white blood cells using the QIAamp DNA
Mini Kit (Qiagen Inc., Valencia, CA) following the Blood
and Body Fluid Spin Protocol (Qiagen). The GSTM1 gen-
otypes were determined using real-time PCR by TaqMan
7500 (Applied Biosystems, Foster City, CA). The forward/
reverse primers, probe and real time PCR conditions
were adapted from Gilliland et al (2002) [18]. All samples
were also analyzed with primers and probes for the
human actin gene to verify the presence of amplifiable
DNA.
After the blood sample was taken, a resting systolic
(BPsys) and diastolic (BPdia) blood pressure was taken
(Table 2).
ECG measurements
Continuous ambulatory electrocardiograms (Holter
ECGs) were collected for three 24-hour slices using a
Mortara H12+ 12-Lead ECG Recorder (Mortara Instru-
ment Co., Milwaukee, WI) sampling at 180 Hz. Elec-
trodes were changed each morning to ensure adequate
skin contact and new batteries and a fresh flash card were
used. A trained research nurse manually edited the
sequence of ECG complexes to ensure proper labeling of
each QRS complex. RR-intervals that were more or less
than 20% of the previous RR-interval were defined as
abnormally long or short intervals and were interpolated
using Mortara algorithms. Subsequent heart rate variabil-
ity (HRV) indices in both the time and frequency
domains were calculated from these edited records (Table
2). A detailed description of the measurements has been
previously published [19]. Data was collected during a 30-
minute period each morning while the subjects rested
quietly in a darkened room.
Time-domain parameters were calculated over a 24-
hour period starting at the beginning of the resting
period. The standard deviation of normal-to-normal
intervals (SDNN), root-mean-square of successive differ-
ences (RMSSD) and percentage of adjacent normal-to-
normal intervals which differ more than 50 ms (pNN50)
were assessed. A 5-minute segment during the end of the
resting period was used to calculate frequency domain
and repolarization indices. From the spectra the fre-
quency bands 0.04-0.15 Hz (low frequency (LF)) and
0.15-0.40 Hz (high frequency (HF)) were calculated in
absolute and heart rate-normalized units (LF_norm and
HF_norm). Total power (TP), the low-to-high frequency
power ratio (LF/HF) and resting heart rate (HR) were also
determined.
Because spatiotemporal heterogeneity of repolarization
contributes to the initiation of arrhythmia, we also calcu-
lated markers of cardiac repolarization including heart
rate (Bazett)-corrected QT interval (QTc), normalized
QT variance (QT norm), QT variability index (QTVI), T
wave amplitude, and T wave complexity together with the
variability (standard deviation) of T wave complexity.
QTc is reported as the average of eight consecutive beats
on a composite of all leads. The normalized QT variance
was calculated by QT_norm = QT_variance/(mean QT)2.
The QT variability index (QTVI) was derived for each
interval according to the equation: QTVI = log10 [(QTv/
QTm
2)/(HRv/HRm
2)] [20] with the heart rate mean (HRm)
Table 1: Hematological measurements.
Inflammation/Coagulation
Acute-phase reaction C-reactive protein (CRP), 
albumin, fibrinogen
Pro-inflammatory cytokines Interleukin-6 (IL-6), tumor 
necrosis factor alpha (TNFα)
Endothelial dysfunction Soluble intercellular 
adhesion molecules-1 
(sICAM-1), soluble vascular 
cell adhesion molecules-1 
(sVCAM-1), soluble 
endothelial-leukocyte 
adhesion molecule (E-
selectin)
Platelet activation Von Willebrand factor (vWf)
Coagulation pathway Factor VII, factor IX, protein C, 
fibrinogen
Fibrinolysis pathway Plasminogen, D-dimer, tissue 
plasminogen activator (t-PA), 
plasminogen activator 
inhibitor (PAI-1)
Blood panel
Blood lipids Total cholesterol (TC), 
triglycerides, very low-
density lipoprotein (VLDL), 
low-density lipoprotein 
(LDL), high-density 
lipoprotein (HDL)
Red blood cells count (RBC) Mean corpuscular volume 
(MCV)
White blood cells count 
(WBC)
Monocytes, neutrophils, 
eosinophils, lymphocytes
T absolute number and 
percentage of WBC
Platelets
Total hemoglobin
Mean corpuscular 
hemoglobin (MCH)Schneider et al. Particle and Fibre Toxicology 2010, 7:14
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and variance (HRv) and QT interval mean (QTm) and
variance (QTv) being computed from the respective time
series for each 5-minute interval. For T wave amplitude,
o r i g i n a l  E C G  l e a d s  I ,  I I ,  V 1  t o  V 6  w e r e  u s e d  a n d  t h e
median value from those eight original leads was taken
for each cardiac cycle and averaged over five minutes. T
wave complexity was measured in each beat by principal
component analysis (PCA) based on all 12 leads and aver-
aged over the 5-minute period.
Altogether, four blood samples, four blood pressure
measurements, four 5-minute resting ECGs, and three
24-hour ECGs were intended to be collected from each
subject.
Air pollution monitoring
Concentrations of fine ambient PM (average from 9 AM -
9 AM) were measured on each clinic day and for the four
prior days with a 3000K Versatile Air Pollution Sampler
(URG Corp., Chapel Hill, NC) [21] located on the EPHD
rooftop approximately 30 meters above ground level. In
addition, daily 24-hour concentrations (midnight to mid-
night) of fine ambient PM2.5 mass were obtained from a
monitoring station located approximately 44 kilometers
(27 miles) east of the EPHD and operated by the State of
North Carolina. The Spearman correlation between both
PM2.5 measurements was 0.85 across the 14 month study
period and the network data was used to impute missing
rooftop data based on a linear regression model. Of thir-
teen daily averages relevant for the health outcome analy-
sis, eleven could be imputed and only two remained
missing.
Continuous 2-minute measurements of air tempera-
ture, barometric pressure and relative humidity were
obtained from the EPHD rooftop and 24-hour averages
were calculated. Rooftop data was complete for the health
outcome analysis, so no imputation was necessary.
Statistical analyses
The study was conducted as a panel study with four
(three for 24-hour ECGs) repeated measurements per
participant. Thus every person acted as his/her own con-
trol which limited the need for an adjustment for patient
characteristics in the analysis.
Data were analyzed using the statistical package SAS
Version 9.1 (SAS Institute, Inc., Cary, NC). For the analy-
sis of the PM effect, additive mixed models with a ran-
dom participant effect and "compound symmetry"
covariance structure were used [22,23]. Model building to
identify meteorological and temporal determinants, as
potential confounders, was done for each outcome vari-
able separately. Model fit was assessed by the Akaike
Information Criterion (AIC). Details on the confounder
selection process can be found in Schneider et al. (2008)
[17].
The exposure, in this case rooftop PM2.5 mass, was con-
sidered as an immediate (lag 0) or a delayed (lag 1 to lag
4) linear effect. Effect estimates are presented as percent-
age changes of the mean outcome variable together with
95%-confidence intervals (CI) for a 10 μg/m3 increment
in ambient PM2.5 mass.
Table 2: Electrocardiogram and blood pressure 
parameters.
Heart rate variability (HRV) (24 h): time domain
RMSSD Root mean square of 
successive differences
SDNN Standard deviation of NN 
(normal-to-normal)
pNN50 Percentage of adjacent NN-
intervals which differ more 
than 50 ms
Heart rate variability (HRV) (5 min at rest): frequency domain
HR Heart rate
TP Total power (approximately 
= 0.40 Hz)
LFa Low frequency band (0.04-
0.15 Hz)
HFa High frequency band (0.15-
0.40 Hz)
LF/HF Low-to-high frequency 
power ratio
Repolarization events (5 min at rest)
QTc Bazett-corrected QT interval 
(correction: QT/sqrt(NN))
QT norm Normalized QT variance
QTVI QT variability index
T wave amplitude Amplitude of T wave
T wave complexity Principal component analysis 
of T wave
Variability of T wave 
complexity
Standard deviation of T wave 
complexity
Blood pressure
BPsys Systolic blood pressure
BPdia Diastolic blood pressure
aRepresented as absolute values of power (unit: ms2) and as the 
relative value of each power component in proportion to total 
power minus the very low frequency component (unit: 
normalized units)Schneider et al. Particle and Fibre Toxicology 2010, 7:14
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Sensitivity analyses were done by changing the covari-
ance structure to first order autocorrelation as well as by
repeating parts of the analysis with PM2.5 values that were
not imputed. In addition, analyses were repeated using
network PM2.5 data imputed with rooftop PM2.5 data as
exposure. Individuals that had experienced PM2.5 values
exceeding 35 μg/m3 during their relevant days of expo-
sure were excluded to examine if health effects occurred
also below current 24-hour U.S. National Ambient Air
Quality Standard (NAAQS). Moreover, to assess the het-
erogeneity across study participants in this repeated mea-
sures study, we examined patient-specific, random slope-
models for selected PM2.5 results.
Effect modification was examined using dichotomous
indicator variables (Table 3). For blood endpoints, we
considered body mass index (BMI) (cut point 30 kg/m2),
age (cut point 60 years), HbA1c (cut point 7%, measured
only once), adiponectin (cut point 3700 ng/ml, mean of
repeated measurements per individual used for group-
ing), MPO (cut point 7 ng/ml, daily level used for group-
ing), ferritin (cut point 60 ng/ml, daily level used for
grouping), and statins intake (yes/no). In addition, effect
modification by aspirin intake (yes/no) was examined for
coagulation markers fibrinogen, factor VII, factor IX, and
protein C. For ECG endpoints, we considered beta-block-
ers intake (yes/no). Cut points were typically near the
median value seen in the 22 participants. In addition,
gene-environment interaction was assessed for the null-
polymorphism of GSTM1.
Results
Participant characteristics
The participants' age ranged between 48 and 78 years,
and almost two thirds of the recruited volunteers were
male. All participants were current non-smokers, but
almost half of them were ex-smokers. Their BMIs ranged
between 20 and 44 kg/m2 with 41% (n = 9) of the partici-
pants being overweight (20-25 kg/m2) and 55% (n = 12)
being obese (≥ 30 kg/m2) (Table 4). Less than 50% had a
systolic blood pressure greater than 140 mmHg indicat-
ing stage 1 hypertension. Duration of type 2 diabetes
ranged from two months to 23 years (Table 5). Most par-
ticipants had a history of hypertension and dyslipidemia.
The majority was treated with oral anti-hyperglycemic
medications and half of them were taking statins and
anti-hypertensives. About two-thirds of the participants
regularly took aspirin.
Table 3: Potential selected effect modifiers.
Clinical characteristics associated with insulin resistance
Body mass index (BMI) Cutpoint 30 kg/m2
Age Cutpoint 60 years
Glycosylated hemoglobin 
A1c (HbA1c)
Cutpoint 7%
Adiponectin-level in blood Cutpoint 3700 ng/ml
Clinical characteristics associated with oxidative stress
Myeloperoxidase (MPO)-
level in blood
Cutpoint 7 ng/ml
Ferritin-level in blood Cutpoint 60 ng/ml
Glutathione S-transferase M1 
(GSTM1) null polymorphism
Yes/No
Medication intake
Beta-adrenergic receptor 
(BB)
Yes/No
Statins Yes/No
Aspirin Yes/No
Table 4: Description of the study population 
characteristics: current non-smoking subjects with type 2 
diabetes mellitus.
Individual Characteristics N = 22 individuals
Mean (± SD) or total number 
N (%)
Age [yrs] 61 (± 8)
Age ≥ 60 yrs 13 (59)
Gender: male 14 (64)
Ethnicity:
Caucasian 15 (68)
African-American 6 (27)
Hispanic-American 1 (5)
Body mass index (BMI) [kg/
m2]
33 (± 7)
Body mass index (BMI) ≥ 30 
kg/m2
12 (55)
Average systolic blood 
pressure ≥ 140 mmHg
9 (41)
Smoking-status
Never-smoker 12 (55)
Ex-smoker 10 (45)
Null polymorphism of 
GSTM1a
10 (45)b
aGSTM1: Glutathione S-transferase M1
bFour subjects declined permission for genetic testing.Schneider et al. Particle and Fibre Toxicology 2010, 7:14
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Table 5: Description of the study population clinical 
characteristics: current non-smoking subjects with type 2 
diabetes mellitus.
Clinical Characteristics N = 22 individuals
Disease history Total number N (%) or 
mean (± SD)
Type 2 diabetes mellitus 22 (100)
Time since diabetes diagnosis [yrs] 6.4 (± 5.0)
Hyperlipidemia 19 (86)
Hypertension 19 (86)
Past myocardial infarction 0 (0)
Coronary artery disease 4 (18)
Peripheral vascular disease 3 (14)
Cerebrovascular disease 1 (5)
Diabetic retinopathy 1 (5)
Diabetic nephropathya 8 (36)
Blood marker levels Total number N (%) 
Glycosylated hemoglobin A1c (HbA1c) ≥ 7%b 9 (41)c
Myeloperoxidase (MPO) ≥ 7 ng/mlb 41 (51)d
Ferritin ≥ 60 ng/mlb 36 (41)e
Adiponectin < 3700 ng/mlb 11 (50)f
Homocysteine ≥ 12 μmol/lb 11 (50)c
Medication intake Total number N (%)
Sulfonylureas 10 (45)
Thiazolidinediones 6 (27)
Metformin 14 (64)
Statins 12 (55)
Aspirin 14 (64)
Beta-adrenergic receptor blockers (BB) 9 (41)
Angiotensin converting enzyme-inhibitors 12 (55)
Calcium-blockers 2 (9)
Diuretics 8 (36)
Angiotension II-receptor blocker 3 (14)
Estrogen 2 (9)
aBased on the screening urine (>30 μg albumin/mg creatinine) on 
spot collection
bGlycosylated hemoglobin A1c was only measured once, 
myeloperoxidase, adiponectin and homocysteine were measured on 
all four visits. For the interaction analysis with myeloperoxidase all 
observations per patient were used as it showed high daily variation 
within individuals. For ferritin all observations per patient were used 
as there were some single missing observations - however, there was 
only low daily variation within individuals. For the interaction 
analysis with adiponectin the mean of the four measurements per 
individual was used. For homocyteine the mean of the four 
measurements per individual was calculated.
cData was missing from two subjects.
dData was missing for 8 observations.
eData was missing for 14 observations.
fData was missing from one subject.
Air pollutant and meteorology measurements
The 24-hour PM2.5 values over the study period were gen-
erally below the U.S. NAAQS of 35 μg/m3 and the mean
over the study period was below annual average NAAQS
of 15 μg/m3 (see Additional File 1: Table S1). The median
of the within-individual PM2.5 ranges was 7.9 μg/m3. Cor-
relations between PM2.5 and meteorology parameters as
well as the time-course of PM2.5 and air temperature dur-
ing the study period can be found in Schneider et al.
(2008) [17].
Description of health outcomes
A description of the patient means for the analyzed blood
and ECG markers can be found in the Additional File 1:
Tables S2-4. The majority of the blood parameters exhib-
ited only low to moderate correlations. The medians of
the patient-specific Spearman correlation coefficients
within repolarization as well as HRV parameters of the 5-
minute ECG were also on average low to moderate. HRV
parameters of the 24-hour ECG correlated moderately to
highly. As expected, BPsys and BPdia showed a high cor-
relation. Correlation tables for all health outcomes can be
found in the additional file (see Additional File 1: Tables
S5-9).
Association of PM2.5 with health outcomes
Blood parameters
The pro-inflammatory cytokines IL-6 and TNFα showed
a strong increment in association with an increment in
PM2.5 with a lag of two days, which persisted for one more
day and then fell back to null (Figure 1). The acute-phase
reactants CRP and fibrinogen did not exhibit as strong a
response, but did increase slightly, however non-signifi-
cantly, with a lag of two days. Albumin, a negative acute-
phase protein, showed a decrease with a lag of one and
two days. No associations with PM2.5 were found with
blood parameters representing endothelial function and
platelet activation (vWf, sICAM-1, sVCAM-1 and E-
selectin) (data not shown). Markers of the coagulation
pathway also showed slight, non-significant changes in
association with PM2.5.  I n  a d d i t i o n  t o  t h e  i n c r e a s e  o f
fibrinogen with a lag of two days, protein C also increased
slightly with the same time lag whereas factor IX
remained unchanged. In contrast, factor VII showed a
slight decrease after one day and also fibrinogen showed a
decreasing tendency with a lag of 3 days (Figure 1). The
fibrinolysis pathway marker PAI-1 increased with a lag of
one day (Figure 1). Plasminogen, D-dimer (a fibrin degen-
eration product) and t-PA were not associated with
PM2.5(data not shown).
Decrements in total cholesterol (TC), high density lipo-
protein (HDL) and low-density lipoprotein (LDL) were
associated with PM exposure with a lag of three to fourSchneider et al. Particle and Fibre Toxicology 2010, 7:14
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days (Figure 2). Red blood cells (RBC) showed a decre-
ment with a lag of one to three days. Consistent with the
RBC associations, mean corpuscular volume (MCV) and
total hemoglobin also had decrements with a similar lag
(Figure 2). Circulating eosinophils (absolute number and
% of WBC) were positively associated with PM2.5 with a
lag of two days, followed by a decrement at lag 3 (Figure
2). None of the other blood panel markers showed mean-
ingful associations with PM2.5 (data not shown).
ECG parameters and blood pressure
Analysis of ECG markers included an interaction term for
the intake of beta-blockers, since it is known that they
can alter ECG response to air pollutants. In the 5-minute
resting ECGs, we did not find any association between
h e a r t  r a t e  o r  f r e q u e n c y  d o m a i n  p a r a m e t e r s  o f  H R V
PM2.5. The 24-hour ECG time domain parameters
showed an association with PM2.5; pNN50 increased with
a lag of 2 and 3 days, and RMSSD increased with a lag of 3
days. SDNN showed a slight immediate increase for the
non-beta-blocker subgroup (Figure 3).
QTc, the QT interval corrected for heart rate,
decreased in association with air pollution at lag 0; and T
wave complexity, a still relatively new marker to study
ventricular repolarization, increased with a lag of 1 and 2
days for participants without beta-blocker intake (Figure
3). T wave amplitude, a marker for the morphology of the
T wave, showed a strong association with PM2.5 in indi-
viduals not on beta-blockers: a decrease starting at lag 0
and persisting for lag 1 and 2 and ending with an increase
at lag 4 (data not shown). Exclusion of one patient
(female, Caucasian, 63 years, BMI = 20 kg/m2, taking
diuretics and estrogens) who showed a very strong asso-
ciation with PM2.5 at lag 0 in the random slopes analysis,
resulted in a loss in the lag 0-association, but led to much
stronger effects for lag 1 and lag 2 and a weaker increase
for lag 4 (Figure 3). The other repolarization markers (QT
norm, QTVI, variability of T wave complexity) did not
show any association with air pollution.
BPsys showed an immediate decrease at lag 0 (-2.7% [-
5.5%; 0.1%]) and together with BPdia an increase with a
delay of four days (BPsys: 2.6% [0.0%; 5.3%]; BPdia: 2.6%
[0.2%; 5.0%]) in association with ambient PM2.5.
Effect modification
Interaction analysis for the inflammatory cytokine IL-6
revealed that stronger associations were observed in the
subgroup with higher BMI, higher HbA1c value, and
lower adiponectin levels, all markers associated with
insulin resistance. Additionally, stronger associations
were observed in those individuals with higher blood fer-
ritin levels as well those carrying the GSTM1 deletion on
both alleles (Figure 4). However, associations between
TNFα and PM2.5 were strongest in the subgroup with
lower BMI, lower HbA1c value, higher adiponectin level,
and with at least one functional GSTM1  allele. Both
cytokines showed a similar effect modification by ferritin
(see Additional File 1: Figure S1). The decrease in factor
VII was found mainly in the subgroup of participants
with high BMI and high HbA1c (data not shown).
Decreases in albumin were mainly found in individuals
with higher BMI, higher HbA1c and lower adiponectin
level (see Additional File 1: Figure S2). The interaction
analysis with aspirin revealed only for protein C that the
lag 2 response was much more pronounced for individu-
Figure 1 Effect estimates for soluble blood-data with 95%-confi-
dence intervals for immediate and delayed associations with 
PM2.5.
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Figure 2 Effect estimates for blood panel-data with 95%-confi-
dence intervals for immediate and delayed associations with 
PM2.5.
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als without aspirin intake. Associations between PM2.5
and RBC or total hemoglobin were strongest in the sub-
group with high BMI, high HBA1c, low adiponectin and
the null GSTM1 genotype, as was seen for IL-6 (Figure 5
and Additional File 1: Figure S3). Eosinophils (absolute
number count as well as % of WBC) increased slightly
more at lag 2 in the subgroup of elevated BMI and HbA1c
(data not shown). In contrast to our previously published
work [17], interaction analysis with MPO levels did not
show any notable effect modifications. No appreciable
effect modification by age or by statins intake was found.
Since the models for the ECG marker analysis included
an interaction term for the intake of beta-blockers, fur-
ther effect modification analysis was not possible due to
small sample size.
Sensitivity analyses
Repeating the analysis without imputed PM values
showed that the effect estimates didn't change apprecia-
bly. Health effects were observed below the current U.S.
NAAQS 24-hour standard for PM2.5 as reducing the data-
set to individuals that never experienced a day above 35
μg/m3  during our relevant exposure period did not
change the estimated effects. Changing the analyzed
exposure from PM2.5 values measured on the roof of the
EPHD in Chapel Hill, NC, to values obtained from fixed
site community monitors resulted in similar effect esti-
mates for the different health outcomes. The estimated
effects were not sensitive to changing the covariance
matrix from compound symmetry to first-order autocor-
relation. Random slopes showed consistent PM2.5 associa-
tions across all study participants for IL-6 and TNFα (see
Additional File 1: Figure S4), QTc, T wave amplitude, and
T wave complexity (data not shown).
Discussion
In this study we reported associations between PM2.5 lev-
els and increased markers of systemic inflammation and
hemostasis/thrombosis in people with diabetes. We also
found PM-associated changes in autonomic nervous sys-
tem control of heart rate as well as changes in ventricular
repolarization. These changes did not occur simultane-
ously, but rather as a wave of response over a 4-5 day
period (Figure 6). As previously reported [17] there is an
immediate change in endothelial function (flow-medi-
ated dilatation); here we also observed rapid changes in
some electrocardiographic parameters (SDNN, QTc), as
well as systolic blood pressure. Other measures of repo-
larization (T wave complexity, T wave amplitude) and
vascular factors associated with clotting/fibrinolysis (Fac-
tor VII, PAI-1) as well as red blood cell-associated indices
(RBCs, MCV, hemoglobin) changed with a lag of 1-3
days. Strong increases in the pro-inflammatory cytokines
I L - 6  a n d  T N F α  a s  w e l l  a s  b l o o d  e o s i n o p h i l s  w e r e
observed with a delay of two days. Changes in markers of
clotting/fibrinolysis (Factor IX, Protein C, fibrinogen) as
well as CRP also occurred with the same lag. Finally, addi-
Figure 3 Effect estimates for ECG-data with 95%-confidence in-
tervals for immediate and delayed associations with PM2.5. All es-
timates are shown for individuals without beta-blocker intake. For T 
wave amplitude one individual was excluded due to very strong asso-
ciations at lag 0. For 24 hour-ECGs lag 0 means the association be-
tween the 24 hour air pollution average concurrent to the ECG 
measurement.
 
Repolarization (5 minute-ECG) - part 2
Lags
01234
-20%
-10%
0%
10%
20%
T wave amplitude
T wave complexity
HRV Time Domain (24 hour-ECG) - part 1
%
-
c
h
a
n
g
e
 
i
n
 
m
e
a
n
 
o
u
t
c
o
m
e
 
v
a
r
i
a
b
l
e
 
p
e
r
 
1
0
μ
g
/
m
³
 
i
n
c
r
e
a
s
e
 
i
n
 
P
M
2
.
5
-30%
0%
30%
60%
90%
120%
RMSSD
pNN50
HRV Time Domain (24 hour-ECG) - part 2
-20%
-10%
0%
10%
20%
SDNN
Repolarization (5 minute-ECG) - part 1
-4%
-2%
0%
2%
4%
QTc
 
Figure 4 Effect modification estimates for interleukin-6 with 
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tional markers of heart rate variability (pNN50, RMSSD)
and blood lipids (TC, LDL, HDL) changed with a lag of 3-
4 days. Effect modification analyses revealed that overall
the effects were more pronounced in the subgroup with
clinical characteristics associated with insulin resistance
(high BMI, high HbA1c, and low adiponectin level).
Characteristics associated with greater oxidative stress
potential (high ferritin level and GSTM1 null) also influ-
enced PM associations found for IL-6 and RBC. It is
unclear whether the immediate effects in endothelial
function and electrocardiographic parameters are caus-
ally related to the more delayed effects in blood parame-
ters or whether they occur via independent mechanisms.
Inflammation and coagulation blood parameters
One of the more robust findings of this study is the asso-
ciation between PM and increases in TNFα and IL-6 lev-
els in the blood. IL-6 acts as both a pro- and anti-
inflammatory cytokine and plays a role in the acute phase
response. TNFα plays a key role in the initiation of sys-
temic inflammation and regulation of immune cells. The
fact that both of these markers of inflammation are ele-
vated in association with PM concentrations, as well as
blood eosinophils, CRP, and fibrinogen (the latter both
not significantly) indicates that ambient levels of PM are
c a p a b l e  o f  i n d u c i n g  a n  i n f l a m m a t o r y  r e s p o n s e  i n  t h e
blood.
Dubowsky et al.(2006) [11] also reported PM-associ-
ated increases in IL-6 and CRP in individuals with diabe-
tes, with significance being achieved with a 3-4 day
moving average of PM. Interestingly, in our study inflam-
matory markers were observed with a lag of two days.
The effect size of the slight, but non-significant increases
in CRP and fibrinogen with lag 2 in our study is in agree-
ment with other air pollution epidemiological studies
[14,15]. Our albumin results should be interpreted cau-
tiously as albumin is often used as a measure of blood
density and is an abundant blood protein that normally
does not vary much. However, it can also be interpreted
as an anti-acute phase protein and therefore the
decreases at lag 1 and lag 2 fit well within the blood
marker interplay of an inflammatory reaction. The strong
delayed increase in eosinophils, an inflammatory leuko-
cyte cell type, adds to this picture. However , the small
increase in eosinophils in our non-asthmatic individuals
is of uncertain significance regarding the inflammatory
status and may also be related to an allergic or Th2
immune response governed by interleukin-5.
Erythrocytes
We observed a decrease in RBC with a lag of 1-3 days, as
well as decreased levels of hemoglobin and MCV. These
findings are consistent with those of Seaton et al. (1999)
[24] and Rückerl et al. (2007) [25], who saw significant
decreases in both parameters in a similar time-frame.
They and others have speculated that PM may cause con-
striction of small blood vessels or alter the adhesive prop-
erties of RBC, thus increasing the time these cells spend
in systemic capillaries and not in larger vessels. Since
increased oxidative stress is known to decrease the life
s p a n  o f  R B C ,  i t  i s  a l s o  p o s s i b l e  t h a t  P M - a s s o c i a t e d
increases in oxidative stress which have been reported by
many, could also result in fewer RBCs or could, perhaps,
injure these sensitive cells causing leakage of hemoglobin
and decreased volume.
Blood lipids
In this study we observed an early decrease in HDL fol-
lowed by decreases in HDL, LDL, and total cholesterol
with a lag of 3-4 days. This is in contrast to an earlier
study in which we observed increased levels of triglycer-
ides and LDL associated with exposure of asthmatics to
coarse PM [26]. However, it is in partial agreement with a
study in which we reported decreased HDL/LDL ratio,
VLDL, and triglycerides in healthy volunteers exposed to
ultrafine particles [19]. One explanation for a PM-associ-
ated decrease in blood lipids is that PM-induced oxidative
stress might modify blood lipids, making them more
prone to adhere to vascular walls and removing them
from the circulation. Kunitomo et al. (2009) [27] reported
that exposure of mice to tobacco smoke resulted in oxida-
Figure 5 Effect modification estimates for red blood cell count 
with 95%-confidence intervals for immediate and delayed asso-
ciations with PM2.5. P-values for the significance of the interaction 
term are given if p ≤ 0.10.
Interaction with Body Mass Index [cut at 30 kg/m²] 
-4%
-2%
0%
2%
4%
Interaction with Adiponectin [cut at 3700 ng/ml]
-4%
-2%
0%
2%
4%
Low
High
Interaction with Glycosylated Hemoglobin A1c [cut at 7 %]
-5%
0%
5%
Interaction with Ferritin [cut at 60 ng/ml]
-4%
-2%
0%
2%
4%
GSTM1 positive
GSTM1 null
Interaction with Glutathione S-Transferase M1 (positive vs. null)
Lags
01234
%
-
c
h
a
n
g
e
 
i
n
 
m
e
a
n
 
r
e
d
 
b
l
o
o
d
 
c
e
l
l
 
c
o
u
n
t
 
p
e
r
 
1
0
µ
g
/
m
³
 
i
n
c
r
e
a
s
e
 
i
n
 
P
M
2
.
5
-4%
-2%
0%
2%
4%
p=0.012
p=0.001 p=0.095
p=0.068
p=0.011Schneider et al. Particle and Fibre Toxicology 2010, 7:14
http://www.particleandfibretoxicology.com/content/7/1/14
Page 10 of 15
t i v e l y  m o d i f i e d  L D L .  A r a u j o  e t  a l .  [ 2 8 ]  r e p o r t e d  t h a t
exposure of mice to ultrafine and fine particles resulted in
oxidized blood lipids as well as an inhibition of the anti-
inflammatory capacity of HDL. Soares et al. (2009) [29]
also reported that in mice exposed to urban air pollution
LDL was oxidized and the lipid content of arterial plaques
was increased. Another possible explanation for the
observed lipid decreases is that they are related to
changes known to occur during acute inflammation and
the acute phase response. According to a review by
Khovidhunkit et al. (2004) [30] infection and inflamma-
tion lead either to no change or to a decrease in serum
cholesterol, LDL as well as HDL levels during the acute-
phase response in humans.
Figure 6 Timing of health effects in association with ambient PM2.5.
Lag 0  Lag 1  Lag 2  Lag 3  Lag 4 
FMD 
SDNN 
QTc 
BPsys 
T wave complexity 
T wave amplitude 
Albumin 
Factor VII 
PAI-1 
HDL 
RBC , MCV , hemoglobin 
IL-6 
TNF 
CRP 
Fib. 
Protein C 
Eosinophils 
pNN50 
TC , LDL , HDL 
RMSSD 
T wave amplitude 
BPsys, BPdia 
, : significant increase or decrease (p0.05) 
, : increased or decreased, but non-significant (p>0.05) Schneider et al. Particle and Fibre Toxicology 2010, 7:14
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Other studies have reported PM-associated changes in
blood lipids. Suwa et al. (2002) [31] demonstrated in
Watanabe heritable hyperlipidemic rabbits that exposure
to PM10 increased the total amount of lipids in aortic
lesions. Sun et al. (2005) [32] showed in a murine model
that the lipid content in the aortic arch increased 1.5-fold
in mice fed a high-fat chow diet and exposed to PM ver-
sus filtered air. In an epidemiologic case-control study of
traffic-exposed police officers, the average values of HDL
cholesterol and triglycerides were elevated in the exposed
group versus an unexposed control group [33].
ECG parameters and blood pressure
In our study, we found a slight immediate increase in
SDNN and delayed positive associations between
RMSSD, pNN50 and air pollution exposure, with the lat-
ter suggesting increased efferent vagal activity. Although
many studies report a decrease in HRV associated with
increasing PM concentration [7,8,34-38] and an exacer-
bation of these adverse PM effects in people with insulin
resistance or diabetes [39,40], positive associations
between PM and HRV have also been reported. An occu-
pational study of NC State Highway Patrol troopers
reported positive associations between PM and heart
beat cycle length, HRV and ectopic beats on the next
morning after their shift [41]. Wheeler et al. (2006) [42]
reported a positive relationship between SDNN and
PM2.5 in patients with pulmonary disease, whereas an
inverse association was observed in patients with cardio-
vascular disease. Moreover, healthy [19] and asthmatic
[43] volunteers exposed to concentrated ambient parti-
cles (CAPs) showed an increase in HF and LF approxi-
mately 18 hours after exposure.
In contrast to HRV, repolarization parameters have
only recently been investigated in air pollution studies. In
our study we observed an immediate negative association
between PM2.5  exposure and QTc, indicative of vagal
stimulation [44]. In addition, we observed changes in T
wave amplitude. Decrements in T wave amplitude corre-
sponded with increments in T wave complexity and vice
versa. These findings are in agreement with other studies.
In a study of male coronary artery disease patients, Hen-
neberger et al. (2005) [45] reported an increase of QTc
associated with organic carbon as well as a decrease of T
wave amplitude and an increase of T wave complexity
associated with ultrafine particles (UFP) and PM2.5.
Frampton et al. (2004) [46] and Samet et al. (2009) [19]
reported reduced QT intervals in healthy individuals
breathing air and UFP with intermittent exercise. Zareba
et al. (2009) [47] demonstrated small changes in QT
interval, T wave amplitude and variability of T wave com-
plexity in subjects exposed to UFP. We observed both
early and late changes in T wave amplitude. It is possible
that changes at earlier lags may be induced directly by
changes via the autonomic nervous system or via changes
in endothelial function (which was observed in our previ-
ous work [17] in the same study population), and changes
at later lags may be triggered by inflammatory reactions.
Recent epidemiological and controlled exposure stud-
ies have reported small increases in BPsys and BPdia in
association with PM at the same day as well as during a 5-
day-average up to a 30-day-average [48,49]. The diabetic
patients in our study showed an immediate decrease in
BPsys and then a much delayed increase of BPsys and
BPdia at a lag of 4 days. However, Ibald-Mulli et al. (2004)
[50] also found small significant decreases in systolic as
well as diastolic blood pressure in association with PM.
We have not observed changes in blood pressure in stud-
ies in which volunteers were exposed to CAPs [51] and
Brook et al. (2002) [52] did not observe changes in blood
pressure in healthy subjects in a controlled exposure
study with inhalation of fine CAPs and ozone. However,
Urch et al. [53] reported an early increase in BPdia after
controlled exposure to CAPs and ozone with the magni-
tude of the BPdia change being associated with the PM2.5
carbon content.
Effect modification
Studies [11,54,55] have shown that patient characteristics
such as high BMI or diseases like diabetes or hyperten-
sion increase the associations between PM and health
outcomes. Obesity represents a pro-inflammatory state
and as such may increase susceptibility to air pollution by
increasing the response to inflammatory stimuli. We pre-
viously reported that markers of insulin resistance such
as obesity and poor glycemic control as indicated by ele-
vated HbA1c and low adiponectin were associated with a
larger PM-associated decrease in endothelial dysfunction
[17]. Here we show a similar finding for IL-6, RBC and
total hemoglobin. Somewhat surprisingly, we observed
that, while these patient characteristics were associated
with increased PM-associated levels of IL-6, TNFα was
increased more in those patients with lower BMI and bet-
ter insulin control. Although both of these cytokines are
associated with inflammation, they do not always travel
together. They can be secreted by different cells under
different control mechanisms and for different purposes.
Blood levels of IL-6, but not TNFα have also been
reported to be an independent predictor of type 2 diabe-
tes after adjustment for BMI [56].
W e  o b s e rv e d  t h a t  i n d i v i d u a l s  w i t h  e l e v a t e d  l e v e l s  o f
blood ferritin had increased levels of IL-6 and TNFα
associated with PM exposure. Serum ferritin is an iron
storage protein and considered a surrogate marker of
total body iron levels. Higher levels of iron, often found in
diabetic individuals, are hypothesized to make one moreSchneider et al. Particle and Fibre Toxicology 2010, 7:14
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prone to inflammation and also to increase oxidative
stress [57]. Excessive absorption and storage of dietary
iron is also thought to contribute to the pathogenesis of
insulin resistance, type 2 diabetes and its complications
[58,59]. Ghio et al. (2008) [60] reported that inhaled
tobacco smoke particles were able to mobilize endoge-
nous iron present in lung lining fluid, resulting in altered
iron homeostasis, increased metal-dependent oxidative
stress, and ultimately increased levels of pulmonary
inflammation. It is possible that patients with higher fer-
ritin-levels would have more iron available for complex-
ing with any particles that enter the vascular system and
would thus have more oxidative stress leading to higher
levels of inflammatory markers. Consistent with this
hypothesis, in our study individuals with ferritin levels
above 60 ng/ml showed much stronger increases in IL-6
and TNFα than those with lower ferritin levels.
Glutathione-S-transferase is a phase II enzyme which
can scavenge oxygen-free radicals, metabolize reactive
oxygen species and detoxify xenobiotics present in PM.
People with a GSTM1 null allele are thought to handle
oxidative stress less effectively and may be more respon-
sive to agents such as PM which increase oxidative stress.
The potential of this genotype to make carriers more sus-
ceptible to PM exposure has already been shown repeat-
edly [55,61-64]. We reported earlier that individuals with
diabetes with the null GSTM1 polymorphism have the
greatest PM-associated decreases in endothelial dysfunc-
tion. Here, we extend these findings by showing that indi-
viduals with diabetes carrying the null allele for GSTM1
also have the most pronounced changes in IL-6, RBC,
total hemoglobin and MCV.
Strengths and limitations
Excellent adherence to the protocol by the volunteers
who attended all clinical visits is one of the study's
strengths. Yet, the design with four successive visits in
one week might not be optimal to detect changes in bio-
markers having longer half-lives, such as fibrinogen.
However, using first order autocorrelation as a covariance
matrix to account for that autocorrelation between the
data from consecutive days did not show strong influence
on the effect estimation. Daily variations could have an
influence on the health outcomes but models were
adjusted for day of the week if AIC proved it to be neces-
sary. Circadian variation was controlled by design, as
measurements on every individual were taken at the same
time of day.
A limitation of the study is the small number of individ-
uals studied. While the numbers are adequate to observe
associations between PM and pro-inflammatory cytok-
ines, there was not enough power to exclude significant
changes in other biomarkers related to inflammation and
coagulation where only trends appeared. A major
strength of the study was the simultaneous measurement
of interacting ECG and blood markers, thereby establish-
ing the temporal relationship of changes in physiological
and biochemical responses to PM2.5 exposure, and pro-
viding insight into the potential mechanisms of air pollu-
tion effects. However, coagulation factors were measured
as antigen levels, which don't necessarily reflect func-
tional levels. As with any study that examines many dif-
ferent end points, multiple testing and as a consequence
the potential for false-positive results can be a problem,
especially with so many effect modifiers.
In this study we used daily PM 2.5 mass values from a
monitoring station located on the rooftop of the EPHD.
In addition, PM2.5 values from a state monitoring station
located 27 miles away from the EPHD were obtained.
There was a strong correlation between these two sets of
measurements, suggesting that we were accurately
assessing ambient exposure of the study participants all
living in a 30 mile radius of Chapel Hill. Thus, while
ambient exposures are measured with some imprecision,
these exposure measurement errors are non-differential
with respect to either true ambient exposure or to the
clinical measurements. As such, these Berkeson measure-
ment errors will tend to bias our results towards the null.
However, we have to acknowledge the possibility that the
reported effect estimates might be modified by co-pollut-
ants that were not measured. A further strength of this
study is the investigation of air pollution effects in a par-
ticularly susceptible subgroup. On the other hand, the
results cannot be generalized to the whole population.
Conclusion
Exposure to elevated levels of ambient fine particulate air
pollution showed a cascade of responses in association
with PM2.5. PM2.5  might immediately alter ventricular
repolarization and increase myocardial vulnerability to
arrhythmias, as well as induce systemic inflammation two
days later suggesting that some mechanisms work quickly
through physiological systems primed to respond quickly,
while some require a greater length of time for the acti-
vated signaling pathways to translate the response. It is
not clear whether the mechanisms are causally related or
independent. This study provides further evidence that
individuals with diabetes appear to be very sensitive to
PM2.5, especially those with higher insulin resistance.
This issue is elevated to a higher level of concern given
that the prevalence of diabetes is likely to increase over
the next two decades.Schneider et al. Particle and Fibre Toxicology 2010, 7:14
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